Radical cell therapy trial aims to reset immune system in tough autoimmune cases
NCT ID NCT07246096
Summary
This early-stage study is testing the safety and initial effectiveness of a new type of cell therapy called universal CAR-T for people with severe autoimmune diseases that have not improved with standard treatments. The therapy involves modifying a patient's own immune cells to target and remove harmful B cells, which are thought to drive these diseases. The study will enroll 60 adults with conditions like lupus, rheumatoid arthritis, or scleroderma to find a safe dose and see if the treatment can control their disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Changhai Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.